NCT04944485

Brief Summary

This clinical trial will be conducted to compare the clinical performance of self adhesive giomer containing flowable composite and putty nanohybrid resin composite in class V cavities over one year follow-up

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 29, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

June 29, 2021

Status Verified

June 1, 2021

Enrollment Period

1 year

First QC Date

June 21, 2021

Last Update Submit

June 28, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessing change in marginal discoloration between time points 3, 6 ,12 months

    Visual inspection with mirror Alpha :There is no visual evidence of any marginal discoloration at the junction of the restoration and the adjacent tooth structure . Bravo :There is visual evidence of shallow marginal discoloration. Charlie : There is visual evidence of deep marginal discoloration toward a pulpal direction.

    3,6,12 months

Secondary Outcomes (1)

  • Assessing change in modified USPHS criteria between time points 3, 6 ,12 months

    3,6,12 months

Study Arms (2)

class V cavities treated with putty nanohybrid resin composite

ACTIVE COMPARATOR

Selective enamel etching will be done and a universal adhesive (Prime\&Bond universal™ ,Dentsply)will be applied to both enamel and dentin. After gentle dryness and solvent evaporation the bonding agent will be cured for 20 seconds. Composite (Neo Spectra™ST, Dentsply, Sirona, USA) will be placed incrementally and light cured for 20 seconds

Other: (Neo Spectra™ ST, Dentsply, Sirona, USA)

class V cavities treated with Self adhesive giomer containing nanohybrid flowable composite

EXPERIMENTAL

Cleaning and gentle air blowing of the preparation. Then applying FIT SA F03 (Low Flow), SHOFU, USA. Spread in a thin layer (≤0.5mm) on the prepared surface with needle tip, microbrush and gently air-blow leave for 20 seconds then light cure for 5 seconds. Then,apply additional increments (≤2mm) of FIT SA and light cure each increment for 10 seconds then finish and polish

Other: (FIT SA F03, SHOFU, USA)

Interventions

Self adhesive giomer containing nanohybrid flowable composite

class V cavities treated with Self adhesive giomer containing nanohybrid flowable composite

Conventional technique using putty nanohybrid resin composite

class V cavities treated with putty nanohybrid resin composite

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with carious anterior or posterior buccal class V lesions.
  • No signs of irreversible pulpitis (vital teeth)
  • Young adult males or females.
  • Acceptable oral hygiene.
  • Co-operative patients approving to participate in the study

You may not qualify if:

  • Patients with a compromised medical history.
  • Severe or active periodontal disease
  • Systemic diseases or severe medical complications (disabilities).
  • Lack of compliance
  • Extensive carious lesion that is in risk of pulp exposure.
  • Rampant caries.
  • History of pain or swelling.
  • Endodontically treated teeth.
  • Mobility grade 1 or 2
  • Non-carious cervical abfraction lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

CMW cement

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The assessors, statistician and the patients will be blinded to intervention/control assessment methods; Triple blinded study. Also, it will not be allowed amongst the examiners to exchange any information throughout the entire study period.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

June 21, 2021

First Posted

June 29, 2021

Study Start

August 1, 2021

Primary Completion

August 1, 2022

Study Completion

August 1, 2022

Last Updated

June 29, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share